| Literature DB >> 35967883 |
Sara Razeghi1, Homayoun Amini1, Zahra Mirsepassi1.
Abstract
Continuity of care has been considered, as a key component of the treatment process, especially after discharge from the hospital. Establishing treatment continuity is critical to achieving successful treatment outcomes. Roozbeh Home Care Program was developed to ensure the continuity of care in patients with severe mental illness. This study aims to investigate the consequences of discontinuing a home care service including; relapse, readmission, service satisfaction, severity and disability, in patients with severe mental illness in Iran. Forty-three patients who received home care service for more than 6 months were included. They were assessed 3 and 6 months after receiving the service; and 12 months after the program discontinuation. There was a significant difference between the hospitalization rate during (0.42 ± 0.64) and 1 year after the program's discontinuation (0.65 ± 1.46). The majority of the caregivers (70%) were highly satisfied with the home care services. Among the patients who received the homecare services, 40.4% were highly satisfied; and 21.2% were moderately satisfied. There was no significant difference between disability (as measured by World Health Organization Disability Assessment Schedule), clinical improvement (as measured by Clinical Global Impression-Improvement Scale), or severity of illness (as measured by Clinical Global Impression Severity of the Illness Scale) during and 1 year after program's discontinuation. During the time of receiving the service, hospitalization rate was reduced. Patients and caregivers were satisfied with the service. Providing psychiatric services at home should be considered as a solution to maintain the continuity of care.Entities:
Keywords: Continuity of care; Homecare; Mental disorders; Psychiatry
Year: 2022 PMID: 35967883 PMCID: PMC9362022 DOI: 10.1007/s40737-022-00294-4
Source DB: PubMed Journal: J Psychosoc Rehabil Ment Health
WHODAS, CGI-I and CGI-S scores test in two group
| Index | N | Mean | SD | t | ||
|---|---|---|---|---|---|---|
| WHODAS | Third month | 37 | 23.43 | 8.42 | − 0.31 | 0.75 |
| Sixth month | 37 | 23.89 | 9.17 | |||
| Third month | 41 | 23.59 | 7.87 | − 1.72 | 0.09 | |
| A year after discontinuation | 41 | 25.85 | 9.32 | |||
| CGI-I | Third month | 44 | 4.48 | 1.19 | 0.19 | 0.84 |
| Sixth month | 44 | 4.43 | 1.11 | |||
| Third month | 40 | 4.53 | 1.17 | − 0.28 | 0.77 | |
| A year after discontinuation | 40 | 4.60 | 0.87 | |||
| CGI-S | Third month | 44 | 3.59 | 1.24 | − 0.74 | 0.46 |
| Sixth month | 44 | 3.73 | 1.14 | |||
| Third month | 43 | 3.63 | 1.27 | − 1.08 | 0.28 | |
| A year after discontinuation | 43 | 3.86 | 1.32 | |||
Group 1: Third month and 6 month after enrollment, Group 2: Third month after enrollment and 1 year after discontinuation
WHODAS World Health Organization Disability Assessment Schedule, CGI-I Clinical Global Impression-Improvement, CGI-S Clinical Global Impression-Severity scale